RU2007143060A - Пищевая добавка для вич-пациентов - Google Patents
Пищевая добавка для вич-пациентов Download PDFInfo
- Publication number
- RU2007143060A RU2007143060A RU2007143060/13A RU2007143060A RU2007143060A RU 2007143060 A RU2007143060 A RU 2007143060A RU 2007143060/13 A RU2007143060/13 A RU 2007143060/13A RU 2007143060 A RU2007143060 A RU 2007143060A RU 2007143060 A RU2007143060 A RU 2007143060A
- Authority
- RU
- Russia
- Prior art keywords
- use according
- composition
- oligosaccharides
- colostrum
- serum
- Prior art date
Links
- 235000015872 dietary supplement Nutrition 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract 13
- 229920001542 oligosaccharide Polymers 0.000 claims abstract 10
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract 8
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims abstract 6
- 230000002378 acidificating effect Effects 0.000 claims abstract 4
- 210000003022 colostrum Anatomy 0.000 claims abstract 4
- 235000021277 colostrum Nutrition 0.000 claims abstract 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims abstract 4
- 235000018417 cysteine Nutrition 0.000 claims abstract 4
- 235000014103 egg white Nutrition 0.000 claims abstract 4
- 210000000969 egg white Anatomy 0.000 claims abstract 4
- 230000007935 neutral effect Effects 0.000 claims abstract 4
- 210000002966 serum Anatomy 0.000 claims abstract 4
- 235000016709 nutrition Nutrition 0.000 claims abstract 3
- BSWPGDZSMHQEBE-LURJTMIESA-N (2r)-2-(diacetylamino)-3-sulfanylpropanoic acid Chemical compound CC(=O)N(C(C)=O)[C@@H](CS)C(O)=O BSWPGDZSMHQEBE-LURJTMIESA-N 0.000 claims abstract 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims abstract 2
- 229920002567 Chondroitin Polymers 0.000 claims abstract 2
- 229920000855 Fucoidan Polymers 0.000 claims abstract 2
- 229920002971 Heparan sulfate Polymers 0.000 claims abstract 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims abstract 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims abstract 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims abstract 2
- 229920002230 Pectic acid Polymers 0.000 claims abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims abstract 2
- 229960004308 acetylcysteine Drugs 0.000 claims abstract 2
- 229940072056 alginate Drugs 0.000 claims abstract 2
- 235000010443 alginic acid Nutrition 0.000 claims abstract 2
- 229920000615 alginic acid Polymers 0.000 claims abstract 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract 2
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 claims abstract 2
- 238000011225 antiretroviral therapy Methods 0.000 claims abstract 2
- 210000004369 blood Anatomy 0.000 claims abstract 2
- 239000008280 blood Substances 0.000 claims abstract 2
- 150000001720 carbohydrates Chemical class 0.000 claims abstract 2
- 235000010418 carrageenan Nutrition 0.000 claims abstract 2
- 239000000679 carrageenan Substances 0.000 claims abstract 2
- 229920001525 carrageenan Polymers 0.000 claims abstract 2
- 229940113118 carrageenan Drugs 0.000 claims abstract 2
- 210000004027 cell Anatomy 0.000 claims abstract 2
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000000194 fatty acid Substances 0.000 claims abstract 2
- 229930195729 fatty acid Natural products 0.000 claims abstract 2
- 150000004665 fatty acids Chemical class 0.000 claims abstract 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract 2
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract 2
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract 2
- 229940098330 gamma linoleic acid Drugs 0.000 claims abstract 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims abstract 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims abstract 2
- 229920000669 heparin Polymers 0.000 claims abstract 2
- 229960002897 heparin Drugs 0.000 claims abstract 2
- 229920002674 hyaluronan Polymers 0.000 claims abstract 2
- 150000002632 lipids Chemical class 0.000 claims abstract 2
- 239000001814 pectin Substances 0.000 claims abstract 2
- 235000010987 pectin Nutrition 0.000 claims abstract 2
- 229920001277 pectin Polymers 0.000 claims abstract 2
- 238000006116 polymerization reaction Methods 0.000 claims abstract 2
- 230000002265 prevention Effects 0.000 claims abstract 2
- 235000018102 proteins Nutrition 0.000 claims abstract 2
- 102000004169 proteins and genes Human genes 0.000 claims abstract 2
- 108090000623 proteins and genes Proteins 0.000 claims abstract 2
- -1 sialoglycans Polymers 0.000 claims abstract 2
- 239000007787 solid Substances 0.000 claims abstract 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
1. Применение кислых и нейтральных олигосахаридов для приготовления композиции, причем указанные кислые олигосахариды получены из пектина, пектата, альгината, хондроитина, гиалуроновых кислот, гепарина, гепарана, сиалогликанов, фукоидана, фукоолигосахаридов или каррагенана, и где указанные нейтральные олигосахариды выбраны из группы, состоящей из галактоолигосахарида, фруктоолигосахарида, трансгалактоолигосахарида, ксилоолигосахарида, лактосахарозы и арабиноолигосахаридов, для лечения и/или профилактики ВИЧ у субъекта-человека, имеющего содержание CD4+ Т-лимфоцитов от 200 до 700 клеток/мкл крови, причем указанный субъект не получает высокоактивной антиретровирусной терапии. ! 2. Применение по п.1, в котором степень полимеризации олигосахарида составляет от 1 до 250, предпочтительно от 3 до 250. ! 3. Применение по п.1, в котором композиция дополнительно содержит цистеин, N-ацетилцистеин, диацетилцистеин, сыворотку, молозиво, яичные белки или их комбинацию, обеспечивая по меньшей мере 100 мг цистеинового эквивалента в суточной дозе. ! 4. Применение по п.3, в котором сыворотка, молозиво или яичные белки по меньшей мере частично гидролизованы. ! 5. Применение по любому из пп.1-4, в котором композиция дополнительно содержит полиненасыщенные жирные кислоты (PUFA). ! 6. Применение по п.5, в котором содержание PUFA составляет по меньшей мере 20% гамма-линолевой кислоты плюс эйкозапентаноевой кислоты в расчете на общее содержание жирных кислот. ! 7. Применение по любому из пп.1-4 и 6, в котором композиция является питательной композицией, содержащей липид, белок и углевод. ! 8. Применение по любому из пп.1-4 и 6, в котором композиция является твердой п�
Claims (8)
1. Применение кислых и нейтральных олигосахаридов для приготовления композиции, причем указанные кислые олигосахариды получены из пектина, пектата, альгината, хондроитина, гиалуроновых кислот, гепарина, гепарана, сиалогликанов, фукоидана, фукоолигосахаридов или каррагенана, и где указанные нейтральные олигосахариды выбраны из группы, состоящей из галактоолигосахарида, фруктоолигосахарида, трансгалактоолигосахарида, ксилоолигосахарида, лактосахарозы и арабиноолигосахаридов, для лечения и/или профилактики ВИЧ у субъекта-человека, имеющего содержание CD4+ Т-лимфоцитов от 200 до 700 клеток/мкл крови, причем указанный субъект не получает высокоактивной антиретровирусной терапии.
2. Применение по п.1, в котором степень полимеризации олигосахарида составляет от 1 до 250, предпочтительно от 3 до 250.
3. Применение по п.1, в котором композиция дополнительно содержит цистеин, N-ацетилцистеин, диацетилцистеин, сыворотку, молозиво, яичные белки или их комбинацию, обеспечивая по меньшей мере 100 мг цистеинового эквивалента в суточной дозе.
4. Применение по п.3, в котором сыворотка, молозиво или яичные белки по меньшей мере частично гидролизованы.
5. Применение по любому из пп.1-4, в котором композиция дополнительно содержит полиненасыщенные жирные кислоты (PUFA).
6. Применение по п.5, в котором содержание PUFA составляет по меньшей мере 20% гамма-линолевой кислоты плюс эйкозапентаноевой кислоты в расчете на общее содержание жирных кислот.
7. Применение по любому из пп.1-4 и 6, в котором композиция является питательной композицией, содержащей липид, белок и углевод.
8. Применение по любому из пп.1-4 и 6, в котором композиция является твердой питательной композицией.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67334205P | 2005-04-21 | 2005-04-21 | |
| EP05103260A EP1721611A1 (en) | 2005-04-21 | 2005-04-21 | Nutritional supplement with oligosaccharides for a category of HIV patients |
| EP05103260.5 | 2005-04-21 | ||
| US60/673,342 | 2005-04-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2007143060A true RU2007143060A (ru) | 2009-06-10 |
Family
ID=34939443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007143060/13A RU2007143060A (ru) | 2005-04-21 | 2006-04-19 | Пищевая добавка для вич-пациентов |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20090082249A1 (ru) |
| EP (2) | EP1721611A1 (ru) |
| JP (1) | JP2008536915A (ru) |
| CN (1) | CN101262783A (ru) |
| AR (1) | AR054256A1 (ru) |
| AU (1) | AU2006237739A1 (ru) |
| BR (1) | BRPI0610784A2 (ru) |
| CA (1) | CA2605210A1 (ru) |
| MX (1) | MX2007013082A (ru) |
| NO (1) | NO20075323L (ru) |
| NZ (1) | NZ562666A (ru) |
| RU (1) | RU2007143060A (ru) |
| WO (1) | WO2006112717A2 (ru) |
| ZA (1) | ZA200709047B (ru) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
| PL208669B1 (pl) * | 2002-08-30 | 2011-05-31 | Campina Bv | Środek pianotwórczy zawierający białko i środek uplastyczniający, jego zastosowanie i sposób wytwarzania środka pianotwórczego |
| EP1597978A1 (en) * | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
| US8252769B2 (en) | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
| EP1723951A1 (en) * | 2005-04-21 | 2006-11-22 | N.V. Nutricia | Nutritional supplement with oligosaccharides for a category of HIV patients |
| US20080015166A1 (en) * | 2004-06-22 | 2008-01-17 | N.V. Nutricia | Barrier Integrity in Hiv Patients |
| ATE471665T1 (de) * | 2005-04-21 | 2010-07-15 | Nutricia Nv | Nahrungsergänzungsmittel für hiv-patienten |
| WO2008156354A1 (en) * | 2007-06-21 | 2008-12-24 | N.V. Nutricia | Modulation of intestinal flora of hiv patients |
| WO2009096772A1 (en) * | 2008-02-01 | 2009-08-06 | N.V. Nutricia | Composition for stimulating natural killer cell activity |
| MY180910A (en) | 2010-12-31 | 2020-12-11 | Abbott Lab | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
| MY171620A (en) | 2010-12-31 | 2019-10-21 | Abbott Lab | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides |
| BR112013016587A2 (pt) | 2010-12-31 | 2016-09-27 | Abbott Lab | formulações nutricionais incluindo oligossacarídeos de leite humano e antioxidantes e usos das mesmas |
| CA2822222C (en) | 2010-12-31 | 2019-05-07 | Abbott Laboratories | Human milk oligosaccharides for modulating inflammation |
| MX355780B (es) | 2010-12-31 | 2018-04-30 | Abbott Lab | Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal. |
| EP3510873A1 (en) | 2010-12-31 | 2019-07-17 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection |
| MY166946A (en) | 2010-12-31 | 2018-07-25 | Abbott Lab | Methods of using human milk oligosaccharides for improving airway respiratory health |
| WO2012177118A1 (en) * | 2011-06-22 | 2012-12-27 | N.V. Nutricia | Method for reducing the occurrence of infection in young children |
| WO2013016111A1 (en) | 2011-07-22 | 2013-01-31 | Abbott Laboratories | Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
| MX368124B (es) | 2011-08-29 | 2019-09-19 | Abbott Lab | Oligosacaridos de leche humana para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal. |
| MX2016012427A (es) | 2014-03-26 | 2017-04-27 | Abbott Lab | Suplemento alimenticio en polvo. |
| WO2017151540A1 (en) | 2016-02-29 | 2017-09-08 | Abbott Laboratories | Nutritional supplement powder |
Family Cites Families (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2981629A (en) * | 1960-04-05 | 1961-04-25 | Lewis F Ginnette | Process of dehydrating foams |
| US4237118A (en) * | 1972-03-06 | 1980-12-02 | Howard Alan N | Dietary supplement and dietary methods employing said supplement for the treatment of obesity |
| JPS5645951B2 (ru) * | 1973-05-21 | 1981-10-29 | ||
| FR2490496A1 (fr) * | 1980-09-19 | 1982-03-26 | Roussel Uclaf | Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant |
| US4438147A (en) * | 1982-06-25 | 1984-03-20 | Societe D'assistance Technique Pour Produits Nestle S.A. | Foaming creamer and method of making same |
| DE3734962C1 (de) * | 1987-10-15 | 1989-01-05 | Luitpold Werk Chem Pharm | Verwendung von Chondroitinpolysulfat zur vorbeugenden,lindernden oder heilenden Behandlung von AIDS und ARC |
| JPH01149730A (ja) * | 1987-12-07 | 1989-06-12 | Osaka Prefecture | レトロウイルス増殖抑制剤 |
| EP0355905B1 (en) * | 1988-08-24 | 1993-01-07 | Akzo N.V. | Heparin fragments and fractions with anti-hiv action |
| JP2782443B2 (ja) * | 1988-12-26 | 1998-07-30 | 將純 吉原 | 抗エイズウィルス剤 |
| ES2033193B1 (es) * | 1990-10-30 | 1994-01-16 | Ganadera Union Ind Agro | Mezcla grasa para nutricion infantil y de adultos. |
| SG49307A1 (en) * | 1991-01-24 | 1998-05-18 | Martek Corp | Microbial oil mixtures and use thereof |
| FR2673812B1 (fr) * | 1991-03-13 | 1994-04-01 | Roussel Uclaf | Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications. |
| JPH04300888A (ja) * | 1991-03-28 | 1992-10-23 | Dainippon Ink & Chem Inc | カルボン酸オリゴ糖エステル硫酸化物 |
| IT1248060B (it) * | 1991-06-14 | 1995-01-05 | Italfarmaco Spa | Eparine acilate come inibitori della replicazione di retrovirus |
| US5629023A (en) * | 1991-12-31 | 1997-05-13 | Bland; Jeffrey S. | Medical food composition for metabolic detoxification |
| US5502041A (en) * | 1992-12-11 | 1996-03-26 | The Center For Innovative Technology | Potent inhibitor of HIV reverse transcriptase |
| US5472952A (en) * | 1993-03-18 | 1995-12-05 | Bristol-Myers Squibb Company | Partially hydrolyzed pectin in nutritional compositions |
| JP3310738B2 (ja) * | 1993-11-10 | 2002-08-05 | 株式会社ロッテ | 低カロリーチョコレート |
| DE4404877C1 (de) * | 1994-02-17 | 1995-03-02 | Ksk Industrielackierungen Gmbh | Lackierverfahren und zur Durchführung des Verfahrens geeignete Lackgießvorrichtung |
| US5444054A (en) * | 1994-04-01 | 1995-08-22 | Abbott Labatories | Method of treating ulcerative colitis |
| US5952314A (en) * | 1994-04-01 | 1999-09-14 | Demichele; Stephen Joseph | Nutritional product for a person having ulcerative colitis |
| US5531989A (en) * | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Immunoglobulin and fiber-containing composition for human gastrointestinal health |
| US5531988A (en) * | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Bacteria and immunoglobulin-containing composition for human gastrointestinal health |
| JPH08151328A (ja) * | 1994-11-28 | 1996-06-11 | Fuji Ratetsukusu Kk | エイズ感染防止潤滑剤 |
| US5733579A (en) * | 1995-04-05 | 1998-03-31 | Abbott Laboratories | Oral rehydration solution containing indigestible oligosaccharides |
| US20020016289A1 (en) * | 1995-06-01 | 2002-02-07 | Orla M. Conneely | Methods for treatment and prevention of helicobacter pylori infection using lactoferrin |
| US5827526A (en) * | 1995-07-11 | 1998-10-27 | Abbott Laboratories | Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans |
| ES2123903T5 (es) * | 1995-08-04 | 2011-02-22 | N.V. Nutricia | Composición nutritiva conteniendo fibra. |
| MY115050A (en) * | 1995-10-16 | 2003-03-31 | Mead Johnson Nutrition Co | Diabetic nutritional product having controlled absorption of carbohydrate |
| JPH10108647A (ja) * | 1996-10-08 | 1998-04-28 | Meiji Seika Kaisha Ltd | 胃切除術後患者用ミネラル補給材 |
| JP4008974B2 (ja) * | 1996-12-12 | 2007-11-14 | 森永乳業株式会社 | ビフィズス菌増殖促進組成物及びその用途 |
| DE19701382A1 (de) * | 1997-01-16 | 1998-07-23 | Nutricia Nv | Kohlenhydratmischung |
| NZ337039A (en) * | 1997-02-21 | 2001-06-29 | Univ Tennessee Res Corp | Use of polyunsaturated fatty acids for reducing the incidence of necrotizing entercolitis |
| US5840361A (en) * | 1997-04-09 | 1998-11-24 | Beech-Nut Nutrition Corporation | Fructan-containing baby food compositions and methods therefor |
| NL1005809C2 (nl) * | 1997-04-14 | 1998-10-19 | Dsm Nv | Poederverfbindmiddelsamenstelling. |
| US5846569A (en) * | 1997-06-20 | 1998-12-08 | Creative Labs, Inc. | Colostrum supplement |
| US6051260A (en) * | 1998-04-07 | 2000-04-18 | Healthcomm International, Inc. | Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity |
| FR2781673B1 (fr) * | 1998-07-28 | 2001-09-28 | Univ Picardie | Utilisation d'un glucuronane en tant qu'agent immunostimulant, procede de preparation |
| DE19836339B4 (de) * | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
| US6231889B1 (en) * | 1998-09-21 | 2001-05-15 | Chronorx, Llc | Unit dosage forms for the treatment of herpes simplex |
| US6794495B1 (en) * | 1998-10-19 | 2004-09-21 | New Nordic Danmark Aps | Composition comprising extensin and, optionally, pectic polysaccharides |
| CN1226933C (zh) * | 1999-01-28 | 2005-11-16 | 雀巢制品公司 | 加香可溶调白料粉 |
| EP1074181A1 (en) * | 1999-08-03 | 2001-02-07 | Societe Des Produits Nestle S.A. | Foaming creamer ingredient and powders containing it |
| DE19940011B4 (de) * | 1999-08-24 | 2009-04-02 | Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte | Alginataufbereitung und deren Verwendung |
| US6737089B2 (en) * | 1999-08-27 | 2004-05-18 | Morinda, Inc. | Morinda citrifolia (Noni) enhanced animal food product |
| DE10006989A1 (de) * | 2000-02-16 | 2001-08-23 | Nutricia Nv | Antiadhäsive Kohlenhydratmischung |
| US6846501B2 (en) * | 2000-04-12 | 2005-01-25 | Mid-America Commercialization Corporation | Traditional snacks having balanced nutritional profiles |
| DE10027050A1 (de) * | 2000-06-02 | 2001-12-13 | Karim Balan | Alginathaltige Zusammensetzung und deren Verwendung |
| US6426110B1 (en) * | 2000-08-11 | 2002-07-30 | Global Health Sciences, Inc. | Low-carbohydrate high-protein creamer powder |
| US20020044988A1 (en) * | 2000-08-22 | 2002-04-18 | Fuchs Eileen C. | Nutritional composition and method for improving protein deposition |
| CN1111541C (zh) * | 2000-09-15 | 2003-06-18 | 青岛海洋大学 | 一种聚甘露糖醛酸硫酸盐 |
| DE10057976B4 (de) * | 2000-11-22 | 2005-02-03 | Südzucker AG Mannheim/Ochsenfurt | Verfahren zur Herstellung von Pektinhydrolyseprodukten |
| US6511696B2 (en) * | 2000-12-13 | 2003-01-28 | Novartis Nutrition Ag | Infant formula with free amino acids and nucleotides |
| AU2002233639B2 (en) * | 2001-02-15 | 2007-03-01 | Adeka Corporation | Products containing $G(b)-glucan |
| WO2003093322A2 (en) * | 2002-04-30 | 2003-11-13 | The Population Council, Inc. | Carrageenan based antimicrobial compositions |
| PL208669B1 (pl) * | 2002-08-30 | 2011-05-31 | Campina Bv | Środek pianotwórczy zawierający białko i środek uplastyczniający, jego zastosowanie i sposób wytwarzania środka pianotwórczego |
| US20040122105A1 (en) * | 2002-09-20 | 2004-06-24 | Griscom Bettle | Transdermal compositions |
| US6974841B1 (en) * | 2002-09-27 | 2005-12-13 | Rapisarda Family Irrevocable Trust | Pet anti-aging wellness supplement |
| US20040219188A1 (en) * | 2003-05-02 | 2004-11-04 | Comer Gail M. | Composition and methods for nutritional management of patients with hepatic disease |
| AU2003904192A0 (en) * | 2003-08-11 | 2003-08-21 | Adelaide Research and Innovaiton Pty Ltd | Method for inhibiting bacterial colonisation |
| PL1721612T3 (pl) * | 2003-10-24 | 2009-09-30 | Nutricia Nv | Immunomodulujące oligosacharydy |
| FR2866203B1 (fr) * | 2004-02-13 | 2006-12-08 | Roquette Freres | Procede de fabrication d'un produit de cuisson a base de gluten |
| EP1597978A1 (en) * | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
| US8252769B2 (en) * | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
| EP1723951A1 (en) * | 2005-04-21 | 2006-11-22 | N.V. Nutricia | Nutritional supplement with oligosaccharides for a category of HIV patients |
| US20080015166A1 (en) * | 2004-06-22 | 2008-01-17 | N.V. Nutricia | Barrier Integrity in Hiv Patients |
| CA2576173A1 (en) * | 2004-07-07 | 2006-02-09 | The General Hospital Corporation | Direct activation of atiii in whole blood and plasma |
| US20070036839A1 (en) * | 2005-07-27 | 2007-02-15 | Jose Antonio Matji Tuduri | Phosphorylated glucomannane polysaccharides containing 1-6 and 1-2 linkages increase weight gain in poultry |
-
2005
- 2005-04-21 EP EP05103260A patent/EP1721611A1/en not_active Withdrawn
-
2006
- 2006-04-19 EP EP06733071A patent/EP1874136A2/en not_active Withdrawn
- 2006-04-19 RU RU2007143060/13A patent/RU2007143060A/ru not_active Application Discontinuation
- 2006-04-19 WO PCT/NL2006/050092 patent/WO2006112717A2/en not_active Ceased
- 2006-04-19 BR BRPI0610784-2A patent/BRPI0610784A2/pt not_active Application Discontinuation
- 2006-04-19 CA CA002605210A patent/CA2605210A1/en not_active Abandoned
- 2006-04-19 CN CNA2006800210770A patent/CN101262783A/zh active Pending
- 2006-04-19 NZ NZ562666A patent/NZ562666A/en not_active IP Right Cessation
- 2006-04-19 AU AU2006237739A patent/AU2006237739A1/en not_active Abandoned
- 2006-04-19 US US11/912,093 patent/US20090082249A1/en not_active Abandoned
- 2006-04-19 MX MX2007013082A patent/MX2007013082A/es not_active Application Discontinuation
- 2006-04-19 JP JP2008507580A patent/JP2008536915A/ja not_active Withdrawn
- 2006-04-21 AR AR20060101604A patent/AR054256A1/es unknown
-
2007
- 2007-10-17 NO NO20075323A patent/NO20075323L/no not_active Application Discontinuation
- 2007-10-19 ZA ZA200709047A patent/ZA200709047B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1874136A2 (en) | 2008-01-09 |
| JP2008536915A (ja) | 2008-09-11 |
| WO2006112717A3 (en) | 2007-07-12 |
| AR054256A1 (es) | 2007-06-13 |
| ZA200709047B (en) | 2008-09-25 |
| CN101262783A (zh) | 2008-09-10 |
| EP1721611A1 (en) | 2006-11-15 |
| WO2006112717A2 (en) | 2006-10-26 |
| MX2007013082A (es) | 2008-01-11 |
| BRPI0610784A2 (pt) | 2010-11-09 |
| US20090082249A1 (en) | 2009-03-26 |
| NO20075323L (no) | 2008-01-21 |
| NZ562666A (en) | 2011-03-31 |
| CA2605210A1 (en) | 2006-10-26 |
| AU2006237739A1 (en) | 2006-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2007143060A (ru) | Пищевая добавка для вич-пациентов | |
| RU2007143061A (ru) | Пищевая добавка для пациентов с вич | |
| ES2344640T3 (es) | Composiciones nutricionales. | |
| US10449248B2 (en) | Nutritional composition for improving the mammalian immune system | |
| RU2636162C2 (ru) | Применение питательной композиции для улучшения мышечной функции и суточной активности | |
| ES2523198T3 (es) | Composición nutricional enteral líquida alta en energía | |
| RU2633071C2 (ru) | Препарат для применения аспартата и витамина в12 или биотина для регуляции кетоновых тел | |
| UA81875C2 (ru) | Нутрицевтическая композиция и ее применение для улучшения целостности интестинального барьера | |
| WO2003037320A1 (en) | Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect | |
| AR054257A1 (es) | Suplemento nutricional para pacientes con hiv | |
| RU2007102053A (ru) | Повышение целостности барьера у больных с вич | |
| WO2009096772A1 (en) | Composition for stimulating natural killer cell activity | |
| Undeland et al. | Seafood and health: what is the full story? | |
| WO2009135959A1 (es) | Producto alimenticio para la nutrición por vía enteral u oral del paciente diabético | |
| Luten | Marine functional food | |
| JP6942174B2 (ja) | 皮膚用組成物 | |
| Garg et al. | A rash imposition from a lifestyle omission | |
| ITRM950772A1 (it) | Preparato dietetico contenente chitosano associato ad altre fibre solubili per il controllo dell'obesita' | |
| WO2015037655A1 (ja) | タンパク質の異化軽減または同化促進のための剤 | |
| JP2011225496A (ja) | 体脂肪蓄積抑制剤、内臓脂肪蓄積抑制剤、肝臓中トリグリセリド上昇抑制剤、又は血中トリグリセリド上昇抑制剤 | |
| Jorgensen et al. | Does human milk DHA level affect functional outcome in infants? | |
| Thilly | In Focus Low-protein diet in chronic kidney disease: from questions of effectiveness to those of feasibility | |
| Jensen et al. | Department of Dermatology, Cuyahoga Falls General Hospital, Cuyahoga Falls, Ohio | |
| Giraldo | NUTRITIONAL THERAPY FOR THE TREATMENT AND PREVENTION OF AIDS SCIENTIFIC BASES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20110111 |